Delivery Order SPE2DB22D1017-SPE2DB24FG0MK
Award Date
7/1/24
Potential Completion Date
7/2/24
Potential Value
$3.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,477.75 firm-fixed-price delivery order is for MESALAMINE ER 0.375 GRAM CAP 120S, a pharmaceutical product. The award has a completion date of June 5, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This federal contract award is a delivery order with a ceiling value of $4,266.70, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of MESALAMINE ER 0.375 GRAM CAP 120S, a pharmaceutical product, with a completion date of September 19, 2024. The contract has a firm fixed price pricing type and is not designated as a set-aside. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,485.02, is a delivery order for 4567340127 - MESALAMINE DR 400 MG CAPSULE 180S. The contract has an ultimate completion date of February 24, 2025 and is a firm fixed price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,896.72 firm fixed-price delivery order is for the supply of MESALAMINE ER 0.375 GRAM CAP 120S, a pharmaceutical product. The contract has an ultimate completion date of November 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide MESALAMINE ER 0.375 GRAM CAP 120S, a pharmaceutical product. The contract has a potential value of $3,490.81 and a completion date of January 31, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,163.57 Firm Fixed Price Delivery Order contract covers the supply of MESALAMINE DR 1.2 GM TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of December 10, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $3,875.61, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for MESALAMINE DR 1.2 GM TABLET 120S, a medication used to treat gastrointestinal conditions. The contract has a firm fixed-price pricing type and an ultimate completion date of January 31, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 120 tablets of the medication Mesalamine Delayed-Release 1.2 gram, with a ceiling value of $2,180.50 and a completion date of June 5, 2025. The contract is not set aside for any special designation. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
This contract award is for the delivery of MESALAMINE ER 0.375 GRAM CAP 120S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on July 26, 2024 with a ceiling value of $2,538.76. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of July 29, 2024. The contract is not designated as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,423.89 firm fixed-price delivery order is for the supply of 4,568,249,081 units of the prescription medication Mesalamine DR 400 mg capsules. The contract has an ultimate completion date of May 15, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...